December 04, 2018 03:15 PM
Mylan is issuing a nationwide voluntary recall of all lots of its blood pressure medicine valsartan, expanding a recall of select batches initiated two weeks ago.
The drugmaker said it was recalling 104 additional lots "out of an abundance of caution" after the valsartan-containing products were found to contain traces of a probable cancer-causing impurity.
The drugs were distributed in the U.S. between March 2017 and November 2018.
Updated: December 04, 2018 03:15 PM
Created: December 04, 2018 03:11 PM
Copyright 2018 - WHEC-TV, LLC A Hubbard Broadcasting Company